Organization and Nature of the Business - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Feb. 28, 2021	Dec. 31, 2021	Jun. 30, 2022
Schedule Of Equity Method Investments [Line Items]
Accumulated deficit		$ (168,324)	$ (186,244)
Adicet Therapeutics [Member]
Schedule Of Equity Method Investments [Line Items]
Accumulated deficit			$ (186,200)
Initial Public Offering
Schedule Of Equity Method Investments [Line Items]
Number of common stock shares sold	10,575,513	7,187,500
Issuance price per shares	$ 13.00	$ 14.00
Underwriting discounts and commissions and other offering expenses	$ 137,500	$ 94,200
Net proceeds received from offering	$ 15,000